Biochemicals and Reagents
Biochemicals and reagents are fundamental substances for research and development in fields such as biotechnology, molecular biology, pharmacology, and medicine. These products are essential for a variety of applications, including compound synthesis, biological sample analysis, metabolic process research, and drug production. At CymitQuimica, we offer a wide selection of high-quality, high-purity biochemicals and reagents suitable for various scientific and industrial needs. Our catalog includes enzymes, antibodies, nucleic acids, amino acids, and many other products, all designed to support researchers and professionals in their research and development projects, ensuring reliable and reproducible results.
Subcategories of "Biochemicals and Reagents"
- Biomolecules(98,562 products)
- By Biological Target(101,024 products)
- By Pharmacological Effects(6,952 products)
- Cryopreservatives(21 products)
- Desinfectants and Related Compounds(28 products)
- Hormones(531 products)
- Plant Biology(6,903 products)
- Secondary Metabolites(14,369 products)
Found 130609 products of "Biochemicals and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-Bromo-4-[4-(2-methoxyphenyl)-1-piperazinyl]-1H-pyrazolo[3,4-d]pyrimidine
CAS:3-Bromo-4-[4-(2-methoxyphenyl)-1-piperazinyl]-1H-pyrazolo[3,4-d]pyrimidine is a synthetic compound, commonly classified as a pyrazolopyrimidine derivative. This type of compound is frequently studied for its potential pharmacological properties and significant role in receptor modulation. Originating from the intricate design of heterocyclic chemistry, it is synthesized through a series of complex reactions involving the fusion of different molecular structures.Formula:C16H17BrN6OPurity:Min. 95%Molecular weight:389.25 g/molSGE-301
CAS:SGE-301 is a peptide inhibitor of Protein interactions. It is used as a research tool to study protein interactions, including the interactions of enzymes with substrates and inhibitors, receptor-ligand interactions, and ion channel activity. SGE-301 can be used in immunological studies to detect the presence of specific antibodies or receptors. It has a high purity and CAS No. 1427208-12-5.Formula:C27H46O2Purity:Min. 95%Molecular weight:402.7 g/molNC9
CAS:NC9 is a research tool that has been used in the study of cell biology, pharmacology, and protein interactions. It is an activator ligand that binds to the receptor with high affinity. The NC9 peptide has been shown to be an inhibitor of ion channels. This product is highly purified with a purity of >98%.Formula:C35H47N5O8SPurity:Min. 95%Molecular weight:697.8 g/molBepridil hydrochloride
CAS:Non-selective calcium channel blockerFormula:C24H35ClN2OPurity:Min. 95%Molecular weight:403 g/mol3-Fluoro-6-methyloxane-2,4,5-triol
CAS:3-Fluoro-6-methyloxane-2,4,5-triol is a synthetic chemical compound belonging to the class of organofluorine molecules, which is structurally derived from naturally occurring carbohydrates. This compound is synthesized through advanced organic chemistry techniques, involving the selective fluorination of methylated sugar derivatives.Formula:C6H11FO4Purity:Min. 95%Molecular weight:166.15 g/molKYA1797K
CAS:KYA1797K is a small molecule that has been shown to activate β-catenin signaling pathways in cancer cells. KYA1797K activates the transcription-polymerase chain reaction (PCR) of genes involved in tumor growth, such as epidermal growth factor and PD-L1, which are not expressed in healthy cells. This drug also promotes the proliferation of pluripotent cells, which have the potential to differentiate into any cell type. KYA1797K has been shown to inhibit tumor growth in animal models and may be useful for the treatment of metastatic colorectal cancer.Formula:C17H11KN2O6S2Purity:Min. 95%Molecular weight:442.51 g/molJMV3002
CAS:JMV3002 is a peptide hormone that belongs to the group of pharmacological treatments. It has been shown to increase energy metabolism in humans. JMV3002 contains three nitrogen atoms, which are necessary for its pharmacological effects. The drug target of JMV3002 is unknown, but it has been shown to decrease glutamate levels and increase fatty acid levels in mice. It also induces insulin resistance in adipose cells and decreases synaptic activity in knockout mice.
Formula:C35H34N6O3Purity:Min. 95%Molecular weight:586.7 g/mol2,2'-(4-(4-Phenoxymethylphenyl)butylimino)diethanol
CAS:2,2'-(4-(4-Phenoxymethylphenyl)butylimino)diethanol is an inhibitor of protein interactions. It is a peptide that binds to the receptor site and prevents the binding of other ligands. 2,2'-(4-(4-Phenoxymethylphenyl)butylimino)diethanol is a high purity reagent for research use in cell biology, pharmacology, and biochemistry. It is also used for antibody production and as a control in immunoassays. 2,2'-(4-(4-Phenoxymethylphenyl)butylimino)diethanol inhibits ion channels by binding to the receptor site and preventing the binding of other ligands.Formula:C21H29NO3Purity:Min. 95%Molecular weight:343.5 g/molPI3K inhibitor B591
CAS:PI3K inhibitor B591 is a selective small molecule inhibitor, which is synthetically derived to target the phosphoinositide 3-kinases (PI3K) signaling pathway. This pathway is crucial in multiple cellular processes including growth, proliferation, and survival. B591 specifically inhibits the catalytic activity of the PI3K enzyme, thus impeding downstream signaling pathways such as the AKT/mTOR axis.Formula:C27H29N3O3Purity:Min. 95%Molecular weight:443.5 g/mol4-Bromo-A23187
CAS:Non-fluorescent Ca2+ ionophore; for calibrating fluorescent Ca2+ probes
Purity:Min. 95%5-Butyl-4-[2,3-difluoro-4-(phenylmethoxy)phenyl]-6-phenyl-2-pyrimidinamine
CAS:Please enquire for more information about 5-Butyl-4-[2,3-difluoro-4-(phenylmethoxy)phenyl]-6-phenyl-2-pyrimidinamine including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C27H25F2N3OPurity:Min. 95%Molecular weight:445.5 g/molCdc42, gst tagged human
CAS:Cdc42 is a guanosine triphosphatase (GTP) binding protein that regulates actin polymerization and cell motility. Cdc42, like other GTPases, is activated by hydrolysis of bound GTP to GDP. The gst-tagged human Cdc42 protein has an N-terminal His-tag followed by the GST tag and the full length cDNA sequence of human Cdc42. The purified recombinant protein is suitable for use in receptor assays, ligand identification, research tools, pharmacology, protein interactions, and antibody production.Purity:Min. 95%ISX 9
CAS:Inducer of cell proliferation and neuronal differentiation
Formula:C11H10N2O2SPurity:Min. 95%Molecular weight:234.28 g/molPAT-048
CAS:PAT-048 is a molecule that has been shown to be effective in vitro for the treatment of scleroderma by inducing cell growth and collagen production. It activates signal transducer and activator of transcription (STAT) proteins, which activate gene expression and regulate cellular proliferation. In vitro studies have also shown that PAT-048 can induce the activation of STATs in red blood cells and in red blood cells treated with bleomycin. This drug is currently undergoing preclinical development, but it may be capable of treating other diseases such as arthritis or chronic obstructive pulmonary disease.Formula:C22H18ClF2N3O2SPurity:Min. 95%Molecular weight:461.9 g/molPht-Asn-OH
CAS:Please enquire for more information about Pht-Asn-OH including the price, delivery time and more detailed product information at the technical inquiry form on this page
Purity:Min. 95%RET inhibitor
CAS:RET inhibitors are a class of drugs that inhibit the RET protein. RET is a tyrosine kinase receptor that is involved in many functions, including neuronal function and tumor growth. RET inhibitors have minimal toxicity and may be useful as potential biomarkers for assessing neuronal function in patients with neurodegenerative diseases. RET inhibitors also have anti-tumor effects against solid tumours, such as colorectal adenocarcinoma. These drugs inhibit the proliferation of cancer cells by blocking epidermal growth factor (EGF) signalling and by inducing matrix effects on tumors. The RET inhibitor cabozantinib has been shown to inhibit the activity of human cyp3a4, which is a cytochrome P450 enzyme responsible for metabolizing many medications. This property makes it more selective than other drugs in its class. Cabozantinib binds to the ATP-binding pocket of RET, inhibiting its kinase activity, leading to cell death.Formula:C17H11KN2O6S2Purity:Min. 95%Molecular weight:442.5 g/molGSK2033
CAS:GSK2033 is a chemical compound that acts as a liver X receptor (LXR) antagonist, primarily sourced from synthetic origins. It functions by binding to the LXR, which is a nuclear receptor involved in regulating the expression of genes controlling lipid metabolism and cholesterol homeostasis. By inhibiting the activation of LXR, GSK2033 decreases lipid and cholesterol synthesis pathways, thereby modulating lipid levels within cells.
Formula:C29H28F3NO5S2Purity:Min. 95%Molecular weight:591.66 g/mol18-Deoxyherboxidiene
CAS:18-Deoxyherboxidiene is a potent inhibitor of kinases, making it an effective anticancer agent. It works by inhibiting the activity of certain proteins that are involved in cancer cell growth and proliferation. This compound has been found to induce apoptosis in cancer cells, leading to their death. 18-Deoxyherboxidiene is a medicinal analog of Herboxidiene, which was originally isolated from a Chinese soil sample. It has shown promising results in preclinical studies as a potential treatment for various types of cancer. In addition, this compound has been detected in human urine samples, indicating its potential for use as a diagnostic tool for cancer detection and monitoring. Its unique properties make it a valuable tool for further research into the development of new cancer treatments.
Formula:C25H42O5Purity:Min. 95%Molecular weight:422.6 g/molQuinazosin
CAS:Quinazosin is an anticancer drug that belongs to the class of kinase inhibitors. It has been shown to induce apoptosis in tumor cells by inhibiting cyclin-dependent kinases. Quinazosin is a potent inhibitor of protein kinase activity and has been used in Chinese herbal medicine for the treatment of cancer. This drug analog has shown promising results in preclinical studies, demonstrating its ability to inhibit the growth and proliferation of various types of cancer cells. Quinazosin is excreted primarily in urine and has a low toxicity profile, making it a potential candidate for future cancer therapy.Formula:C17H23N5O2Purity:Min. 95%Molecular weight:329.4 g/mol
![3-Bromo-4-[4-(2-methoxyphenyl)-1-piperazinyl]-1H-pyrazolo[3,4-d]pyrimidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWJB34088.webp&w=3840&q=75)
![5-Butyl-4-[2,3-difluoro-4-(phenylmethoxy)phenyl]-6-phenyl-2-pyrimidinamine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FDQD74578.webp&w=3840&q=75)
